Key points are not available for this paper at this time.
ALI (<18) at diagnosis is an independent marker of poor outcome in patients with advanced NSCLC.
Jafri et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: